Target intelligence / Profile preview

Homeobox protein Hox-A cluster (HOXA)

Target
HOXA
Molecular classification
Transcription factor, Homeodomain protein, DNA-binding protein
01

Overview

The Homeobox protein Hox-A cluster (HOXA) is a group of 11 highly conserved transcription factors located on chromosome 7p15.2 that are fundamental to embryonic development and positional identity [Wikipedia]. These proteins contain a characteristic 60-amino acid homeodomain that binds to specific DNA sequences to regulate genes involved in morphogenesis and cell differentiation [UniProt]. In adult physiology, members of the HOXA cluster, particularly HOXA9, are essential for the maintenance and differentiation of hematopoietic stem cells [PubMed: 30310040]. Dysregulation of the HOXA cluster is a significant driver in several cancers; for instance, the overexpression of HOXA9 and HOXA10 is a hallmark of aggressive leukemias harboring MLL (KMT2A) rearrangements or NPM1 mutations [PubMed: 28254383]. While direct targeting of transcription factors is challenging, the HOXA cluster is currently targeted indirectly through Menin-MLL inhibitors like Revumenib, which disrupt the epigenetic complexes required for HOXA transcription [ClinicalTrials.gov]. Additionally, experimental peptides like HXR9 aim to disrupt the interaction between HOX proteins and their required PBX cofactors to induce apoptosis in cancer cells [PubMed: 25151357].

Other names
HOX1 clusterHomeobox A clusterHOXA1-HOXA13HOXA gene cluster
02

Mechanism of action

Inhibition of the Menin-KMT2A (MLL) interaction to downregulate HOXA gene expression; disruption of HOX-PBX protein-protein interactions to prevent transcriptional activity.

03

Biological functions

Embryonic developmentAnterior-posterior patterningHematopoiesisCell differentiationOrganogenesisEndometrial receptivity
04

Disease associations

Acute myeloid leukemia (AML)Acute lymphoblastic leukemia (ALL)Breast cancerOvarian cancerHand-foot-genital syndromeEndometriosis
05

Safety considerations

Potential for developmental toxicity and teratogenicityImpact on normal hematopoietic stem cell maintenanceDifferentiation syndrome (associated with Menin inhibitors)QT prolongationGastrointestinal toxicity
06

Interacting drugs

Revumenib (SNDX-5613)

4 more in the full profile.

07

Biomarkers

HOXA9 mRNA expression levelsHOXA10 expressionKMT2A (MLL) rearrangement statusNPM1 mutation status

Beyond the preview

Go deeper on Homeobox protein Hox-A cluster (HOXA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Homeobox protein Hox-A cluster (HOXA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call